Skip to main content
Equibles
ZBH logo

ZBH · Zimmer Biomet Holdings, Inc.

Track ZBH — free

Use ZBH with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about ZBH

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$100.65 +1.08 (+1.08%) At close · Aug 14
Market Cap
$19.20B
Shares
190.74M

Zimmer Biomet Holdings, Inc. Earnings Call Transcripts

Every quarterly earnings call for Zimmer Biomet Holdings, Inc. (ZBH) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▼0.9% $1.67B $194.00M '22 Q3 22-11-02 ▲2.7% $1.83B −$130.50M '22 Q4 23-02-03 ▲10.1% $1.83B $232.50M '23 Q1 23-05-02 ▲4.9% $1.87B $209.60M '23 Q2 23-08-01 ▲5% $1.75B $162.70M '23 Q3 23-11-07 ▲6.3% $1.94B $419.20M '23 Q4 24-02-08 ▲3.2% $1.89B $172.40M '24 Q1 24-05-02 ▲3.9% $1.94B $242.80M '24 Q2 24-08-07 ▲4% $1.82B $249.10M '24 Q3 24-10-30 ▲4.3% $2.02B $239.50M '24 Q4 25-02-06 ▲1.1% $1.91B $182.00M '25 Q1 25-05-05 ▲7% $2.08B $152.80M '25 Q2 25-08-07 ▲9.7% $2.00B $230.90M '25 Q3 25-11-05 ▲10.9% $2.24B $139.40M '25 Q4 26-02-10 ▲9.3% $2.09B $238.10M '26 Q1 26-04-28 LATEST ▲4.8% $2.18B $198.30M '26 Q2 26-08-05
Earnings call
FY26 · Q2
2026-08-05
Zimmer Biomet Holdings, Inc. Q2 FY2026 Earnings Call
Revenue
$2.18B
▲ 4.8% YoY
Diluted EPS
$1.03
▲ 33.8% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-04-28
Zimmer Biomet Holdings, Inc. Q1 FY2026 Earnings Call
Confident tone 2026 outlook and guidance U.S. go-to-market transition Paragon 28 acquisition
Revenue
$2.09B
▲ 9.3% YoY
Diluted EPS
$1.22
▲ 34.1% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-10
Zimmer Biomet Holdings, Inc. Q4 FY2025 Earnings Call
Confident tone 2026 Financial Guidance ASC Channel Opportunity SCT / Craniomaxillofacial-Thoracic
Revenue
$2.24B*
▲ 10.9% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-05
Zimmer Biomet Holdings, Inc. Q3 FY2025 Earnings Call
Positive tone U.S. revenue acceleration Restorative therapies weakness Paragon 28 integration
Revenue
$2.00B
▲ 9.7% YoY
Diluted EPS
$1.16
▼ 5.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-07
Zimmer Biomet Holdings, Inc. Q2 FY2025 Earnings Call
Confident tone Monogram Technologies Acquisition (Autonomous Robotics) Paragon 28 Integration and M&A Discipline Second Half 2025 Growth Acceleration and Guidance Raise
Revenue
$2.08B
▲ 7% YoY
Diluted EPS
$0.77
▼ 34.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-05
Zimmer Biomet Holdings, Inc. Q1 FY2025 Earnings Call
Positive tone Paragon 28 acquisition integration Tariffs and offsetting actions Quarterly financial performance
Revenue
$1.91B
▲ 1.1% YoY
Diluted EPS
$0.91
▲ 8.3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-06
Zimmer Biomet Holdings, Inc. Q4 FY2024 Earnings Call
Confident tone U.S. market operational excellence Paragon 28 acquisition Constant currency revenue growth
Revenue
$2.02B*
▲ 4.3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-10-30
Zimmer Biomet Holdings, Inc. Q3 FY2024 Earnings Call
Confident tone Hips business performance Pricing environment ERP implementation recovery
Revenue
$1.82B
▲ 4% YoY
Diluted EPS
$1.23
▲ 59.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-07
Zimmer Biomet Holdings, Inc. Q2 FY2024 Earnings Call
Confident tone ROSA robotics and enabling technologies S.E.T. segment diversification Operational excellence and margin outlook
Revenue
$1.94B
▲ 3.9% YoY
Diluted EPS
$1.18
▲ 18% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-02
Zimmer Biomet Holdings, Inc. Q1 FY2024 Earnings Call
Confident tone Innovation and Product Pipeline Margin Expansion Operational Excellence and Restructuring
Revenue
$1.89B
▲ 3.2% YoY
Diluted EPS
$0.84
▼ 24.3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-08
Zimmer Biomet Holdings, Inc. Q4 FY2023 Earnings Call
Confident tone 2024 Guidance and Long-Term Commitments Innovation and Product Pipeline M&A and Balance Sheet
Revenue
$1.94B*
▲ 6.3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-07
Zimmer Biomet Holdings, Inc. Q3 FY2023 Earnings Call
Revenue
$1.75B
▲ 5% YoY
Diluted EPS
$0.77
▼ 16.3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-01
Zimmer Biomet Holdings, Inc. Q2 FY2023 Earnings Call
Revenue
$1.87B
▲ 4.9% YoY
Diluted EPS
$1.00
▲ 37% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-02
Zimmer Biomet Holdings, Inc. Q1 FY2023 Earnings Call
Revenue
$1.83B
▲ 10.1% YoY
Diluted EPS
$1.11
▲ 1485.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-03
Zimmer Biomet Holdings, Inc. Q4 FY2022 Earnings Call
Revenue
$1.83B*
▲ 2.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-02
Zimmer Biomet Holdings, Inc. Q3 FY2022 Earnings Call
Revenue
$1.67B
▼ 0.9% YoY
Diluted EPS
$0.92
▲ 33.3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-02
Zimmer Biomet Holdings, Inc. Q2 FY2022 Earnings Call
Revenue
$1.78B
▲ 1% YoY
Diluted EPS
$0.73
▲ 9% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-03
Zimmer Biomet Holdings, Inc. Q1 FY2022 Earnings Call
Revenue
$1.66B
▲ 3.9% YoY
Diluted EPS
$0.07
▼ 92.6% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-07
Zimmer Biomet Holdings, Inc. Q4 FY2021 Earnings Call
Revenue
$1.78B*
▼ 14.8% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-04
Zimmer Biomet Holdings, Inc. Q3 FY2021 Earnings Call
Revenue
$1.69B
▼ 12.6% YoY
Diluted EPS
$0.69
▼ 38.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-03
Zimmer Biomet Holdings, Inc. Q2 FY2021 Earnings Call
Revenue
$1.76B
▲ 43.8% YoY
Diluted EPS
$0.67
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-04
Zimmer Biomet Holdings, Inc. Q1 FY2021 Earnings Call
Revenue
$1.60B
▼ 10.2% YoY
Diluted EPS
$0.94
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-02-05
Zimmer Biomet Holdings, Inc. Q4 FY2020 Earnings Call
Revenue
$2.09B
▼ 1.9% YoY
Diluted EPS
$1.54
▲ 3.2% YoY
Gross margin
61.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-06
Zimmer Biomet Holdings, Inc. Q3 FY2020 Earnings Call
Revenue
$1.93B
▲ 1.9% YoY
Diluted EPS
$1.13
▼ 44.2% YoY
Gross margin
62.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-04
Zimmer Biomet Holdings, Inc. Q2 FY2020 Earnings Call
Revenue
$1.23B
▼ 38.3% YoY
Diluted EPS
$-0.97
▼ 253.8% YoY
Gross margin
53.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-04-08
Zimmer Biomet Holdings, Inc. Q1 FY2020 Earnings Call
Revenue
$1.78B
▼ 9.7% YoY
Diluted EPS
$-2.39
▼ 305% YoY
Gross margin
64.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-02-04
Zimmer Biomet Holdings, Inc. Q4 FY2019 Earnings Call
Revenue
$2.13B
▲ 2.6% YoY
Diluted EPS
$1.50
Gross margin
65.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–27 of 27 earnings calls
Key facts CIK 1136869 CUSIP 98956P102 13F (30d) 828 filings 788 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)